Skip to content
Menu
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Gyre Therapeutics, Inc. GYRE

Full chart Compare
Set alert

Price alert · GYRE

All alert types
4.31 USD +0.01 (+0.23%)

At closeNov 13, 2026, 5:48 PM EST

4.30 -0.01 -0.23%

After hours · Nov 13, 5:48 PM ET

4.15 Day range 4.73
3.97 52-week range 9.14
YTD
-38.95%
1 year
-46.66%

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Sign in

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Sign in

Financial health

Altman Z-Score

7.82 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E 125×
FY 2016: -6.7×FY 2017: -27.5×FY 2018: -44.2×FY 2019: -23.2×FY 2020: -32.3×FY 2021: -4.8×FY 2022: 265×FY 2023: -18.2×FY 2024: 86.4×FY 2025: 125×
FY 2016 5y median 86.4× FY 2025
P/S 5.4×
FY 2016: 285×FY 2017: 688×FY 2018: 221194×FY 2019: 0.0×FY 2020: 86.7×FY 2021: 57.0×FY 2022: 5.9×FY 2023: 14.9×FY 2024: 9.7×FY 2025: 5.4×
FY 2016 5y median 9.7× FY 2025
P/B 5.9×
FY 2016: 7.1×FY 2017: 22.8×FY 2018: 11.1×FY 2019: 17.9×FY 2020: 23.9×FY 2021: 10.2×FY 2022: 14.2×FY 2023: -107×FY 2024: 16.3×FY 2025: 5.9×
FY 2016 5y median 10.2× FY 2025
P/FCF -3504×
FY 2016: -6.0×FY 2017: -35.1×FY 2018: -45.9×FY 2019: -28.1×FY 2020: -32.8×FY 2021: -4.9×FY 2022: 106×FY 2023: 97.7×FY 2024: -152×FY 2025: -3504×
FY 2016 5y median -4.9× FY 2025
EV/EBITDA 35.2×
FY 2016: -6.1×FY 2017: -31.9×FY 2018: -38.3×FY 2019: -22.0×FY 2020: -31.8×FY 2021: -4.3×FY 2022: 54.8×FY 2023: 81.6×FY 2024: 57.2×FY 2025: 35.2×
FY 2016 5y median 54.8× FY 2025
EV/Sales 5.1×
FY 2016: 308×FY 2017: 679×FY 2018: 215992×FY 2019: 0.0×FY 2020: 85.3×FY 2021: 51.3×FY 2022: 5.6×FY 2023: 14.6×FY 2024: 9.6×FY 2025: 5.1×
FY 2016 5y median 9.6× FY 2025
FCF Yield -0.0%
FY 2016: -16.6%FY 2017: -2.8%FY 2018: -2.2%FY 2019: -3.6%FY 2020: -3.0%FY 2021: -20.2%FY 2022: 0.9%FY 2023: 1.0%FY 2024: -0.7%FY 2025: -0.0%
FY 2016 5y median -0.0% FY 2025

Profitability

Gross Margin 95.4%
FY 2016: -2545.4%FY 2017: 83.0%FY 2018: -2383.3%FY 2019: 0.0%FY 2020: 56.3%FY 2021: -4.5%FY 2022: 95.3%FY 2023: 95.9%FY 2024: 96.3%FY 2025: 95.4%
FY 2016 5y median 95.4% FY 2025
Operating Margin 9.9%
FY 2016: -5117.3%FY 2017: -2143.6%FY 2018: -563700.0%FY 2019: 0.0%FY 2020: -273.9%FY 2021: -1141.0%FY 2022: 9.0%FY 2023: -59.3%FY 2024: 15.3%FY 2025: 9.9%
FY 2016 5y median 9.0% FY 2025
Net Margin 4.3%
FY 2016: -4246.9%FY 2017: -2118.0%FY 2018: -500916.7%FY 2019: 0.0%FY 2020: -265.1%FY 2021: -1198.3%FY 2022: 2.3%FY 2023: -81.9%FY 2024: 11.4%FY 2025: 4.3%
FY 2016 5y median 2.3% FY 2025
ROE 4.7%
FY 2016: -105.4%FY 2017: -70.1%FY 2018: -25.1%FY 2019: -80.7%FY 2020: -73.0%FY 2021: -214.0%FY 2022: 5.4%FY 2023: 587.1%FY 2024: 19.1%FY 2025: 4.7%
FY 2016 5y median 5.4% FY 2025
ROIC 5.3%
FY 2016: -57.5%FY 2017: -60.9%FY 2018: -28.2%FY 2019: -81.7%FY 2020: -72.9%FY 2021: -192.6%FY 2022: 5.8%FY 2023: -69.5%FY 2024: 11.7%FY 2025: 5.3%
FY 2016 5y median 5.3% FY 2025
ROA 3.0%
FY 2016: -44.5%FY 2017: -54.6%FY 2018: -24.1%FY 2019: -56.0%FY 2020: -58.6%FY 2021: -158.0%FY 2022: 2.7%FY 2023: -79.7%FY 2024: 9.6%FY 2025: 3.0%
FY 2016 5y median 2.7% FY 2025

Growth (YoY)

Revenue 10.2%
FY 2016: -77.2%FY 2017: 155.1%FY 2018: -99.4%FY 2019: -100.0%FY 2020: 0.0%FY 2021: -65.0%FY 2022: 1294.0%FY 2023: 10.9%FY 2024: -6.8%FY 2025: 10.2%
FY 2016 FY 2025
Operating Income -29.2%
FY 2016: -47.9%FY 2017: -6.9%FY 2018: -55.0%FY 2019: -69.3%FY 2020: -0.2%FY 2021: -45.9%FY 2022: 111.0%FY 2023: -830.5%FY 2024: 124.1%FY 2025: -29.2%
FY 2016 FY 2025
EPS (diluted) -55.0%
FY 2016: 56.5%FY 2017: 65.8%FY 2018: 64.0%FY 2019: -64.6%FY 2020: 33.6%FY 2021: 2.0%FY 2022: 101.0%FY 2023: -4800.0%FY 2024: 103.5%FY 2025: -55.0%
FY 2016 FY 2025
Free Cash Flow 97.3%
FY 2016: 2.3%FY 2017: -5.4%FY 2018: -44.9%FY 2019: -51.0%FY 2020: -26.6%FY 2021: -52.9%FY 2022: 106.7%FY 2023: 204.7%FY 2024: -139.1%FY 2025: 97.3%
FY 2016 FY 2025

Financial Health

Current Ratio 5.6×
FY 2016: 1.7×FY 2017: 4.5×FY 2018: 25.8×FY 2019: 3.3×FY 2020: 5.0×FY 2021: 3.6×FY 2022: 4.1×FY 2023: 2.9×FY 2024: 3.3×FY 2025: 5.6×
FY 2016 5y median 3.6× FY 2025
Quick Ratio 5.0×
FY 2016: 0.8×FY 2017: 3.9×FY 2018: 25.8×FY 2019: 3.3×FY 2020: 5.0×FY 2021: 3.6×FY 2022: 3.6×FY 2023: 2.6×FY 2024: 3.0×FY 2025: 5.0×
FY 2016 5y median 3.6× FY 2025
Debt / Equity 0.0×
FY 2016: 1.2×FY 2017: 0.2×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.0×FY 2023: -0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -2.1×
FY 2016: -0.5×FY 2017: 0.4×FY 2018: 0.9×FY 2019: 0.2×FY 2020: 0.5×FY 2021: 0.5×FY 2022: -2.3×FY 2023: -1.6×FY 2024: -0.6×FY 2025: -2.1×
FY 2016 5y median -1.6× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.6%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 269.8%FY 2023: 14.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: -18.3%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 70524.5%FY 2023: -255.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31